BRAGG PEAK LOCALIZATION BY RADIOACTIVE BEAMS

通过放射性束进行布拉格峰定位

基本信息

项目摘要

The Bragg peak therapy of cancer patients with heavy charged particles requires precise localization of the Bragg peak on a tumor volume. A slight error can cause severe underdosing of the tumor region and overdosing of the nearby critical organs. For precise localization of the Bragg peak, one requires and experimentally measured value of the water equivalent thickness between the point of entry and the target volume. Between these two end points there can be unknown amounts of bone, tissue, sinus, air etc. Presently used CT techniques may not be as reliable as desired, especially when there is a large amount of thick bone or air path. We have a technique which uses high energy radioactive beam and a sensitive positron camera, which, we expect, will achieve the desired accuracy. In this technique, radioactive particles such as 19Ne or 11C are used. Both of these particles decay by emitting positrons, which then annihilate with the medium electrons to produce two gamma rays, separated by 180 degrees. These gamma rays can then be detected in coincidence mode by a positron camera to locate their origin in space. Through adjustment of the energy of the radioactive particles (mostly 19Ne will be used), they will be stopped on the location of the tumor, verifiable by the positron camera. This method provides a direct measure of the required water equivalent thickness. This technique will be applied in the treatment position (on-line) and just before the actual therapy. Unlike X-rays (used in CT), radioactive particles have penetration properties that are very similar to those of the heavy charged particles used in Bragg peak therapy. the value of the water equivalent thickness measured by a radioactive beam is then directly applicable for treatment planning with heavy charged particles. Precise delivery of Bragg peak dose on a tumor volume, while sparing the normal cells and hearby critical organs, constitutes and extremely important component of the evaluation of heavy particle treatment modality. This is a long term goal of the laboratory.
重带电粒子对癌症患者的布拉格峰治疗

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALOKE CHATTERJEE其他文献

ALOKE CHATTERJEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALOKE CHATTERJEE', 18)}}的其他基金

BRAGG PEAK LOCALIZATION BY RADIOACTIVE BEAMS
通过放射性束进行布拉格峰定位
  • 批准号:
    3167514
  • 财政年份:
    1980
  • 资助金额:
    $ 22.89万
  • 项目类别:

相似海外基金

Catch and Release Radiolabeled Peptides: a new technology for radiotracer development
捕获并释放放射性标记肽:放射性示踪剂开发的新技术
  • 批准号:
    10593475
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
Fibrosis Associated Protein Inhibitor (FAPI) radiotracer-based imaging to identify fibrosis activity in intestinal Crohn's Disease (FATE-CD)
基于纤维化相关蛋白抑制剂 (FAPI) 的放射性示踪成像,可识别肠道克罗恩病 (FATE-CD) 中的纤维化活动
  • 批准号:
    MR/X030784/1
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
Development of a novel ara h 2 radiotracer for studying peanut allergies
开发用于研究花生过敏的新型 ara h 2 放射性示踪剂
  • 批准号:
    487205
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Studentship Programs
MICA: [18F]LW223: a superior TSPO PET radiotracer for a clinical breakthrough to detect regional tissue inflammation
MICA:[18F]LW223:一种卓越的 TSPO PET 放射性示踪剂,在检测局部组织炎症方面取得了临床突破
  • 批准号:
    MR/W029464/1
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
New approaches to carbon-11 labeled carbonyl and thiocarbonyl groups for positron emission tomography radiotracer synthesis and development
用于正电子发射断层扫描放射性示踪剂合成和开发的碳 11 标记羰基和硫代羰基的新方法
  • 批准号:
    RGPIN-2017-06167
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Discovery Grants Program - Individual
Development of Carbon-11-Labelled Carbonyls for PET Radiotracer Probes
用于 PET 放射性示踪剂探针的碳 11 标记羰基化合物的开发
  • 批准号:
    559805-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
In vivo Quantification of Synaptic Density in Youth With High-risk Cannabis and Alcohol Use: A Positron Emission Tomography Study With the Synaptic Vesicle Glycoprotein 2A Radiotracer [F-18]SynVesT-1
高风险大麻和酒精使用青少年突触密度的体内定量:使用突触囊泡糖蛋白 2A 放射性示踪剂 [F-18]SynVesT-1 进行的正电子发射断层扫描研究
  • 批准号:
    468126
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Operating Grants
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
开发新的放射性示踪剂来研究免疫细胞动员颗粒酶蛋白水解活性
  • 批准号:
    10231735
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
开发新的放射性示踪剂来研究免疫细胞动员颗粒酶蛋白水解活性
  • 批准号:
    10395587
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
开发新的放射性示踪剂来研究免疫细胞动员颗粒酶蛋白水解活性
  • 批准号:
    10591415
  • 财政年份:
    2021
  • 资助金额:
    $ 22.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了